The purpose of this study is to evaluate point of care SARS-Cov2 Virus IgG/IgM rapid test cassette Clungene test and correlate it with the standard method of testing in inpatients who have tested positive or negative for COVID19.
This is a laboratory testing study using the SARS-Cov2 Virus IgG/IgM rapid test cassette Clungene test to determine the presence of IgM and IgG antibodies in subjects who have tested negative or positive for COVID-19. The study is observational and subjects will be assigned to one of two arms depending on the results of their nCOVID-19 test.
Study Type
OBSERVATIONAL
Enrollment
90
Blood will be tested for the presence of IgG and IgM antibodies using the Clungene rapid test cassette.
Fadi A. Haddad MD Inc.
La Mesa, California, United States
RECRUITINGSharp Grossmont Hospital
La Mesa, California, United States
RECRUITINGSharp Memorial Hosptial
San Diego, California, United States
RECRUITINGIgG/IgM antibodies
Presence of IgG and/or IgM antibodies
Time frame: from date of consent to date of test completion, up to 40 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.